You are here

Allergan

Allergan, Novartis ink NASH partnership

BioPharma Dive

Wed, 04/19/17 - 10:02 am

Restasis' first foray into Facebook drives big results for Allergan

Fierce Pharma

Mon, 04/10/17 - 10:03 am

dry eye disease

Allergan To Test Botox For Depression Despite Mixed Results

Forbes

Thu, 04/6/17 - 10:04 am

clinical depression

clinical trials

Allergan's CEO pay plummets by 80% without big M&A and strong financials

Fierce Pharma

Mon, 03/27/17 - 10:29 pm

Allergan, Paratek Pharma report positive results in late-stage trial of acne treatment

Marketwatch

Mon, 03/27/17 - 10:57 am

A Foamix acne drug PhIII bombs, sending shares into a tailspin

Endpoints

Mon, 03/27/17 - 10:33 am

Califf cautions against lowering FDA standards; Editas outlines $1B milestone package

Endpoints

Thu, 03/23/17 - 09:49 pm

Court allows Allergan shareholders to go after Ackman, Valeant as a class

Bizjournals.com

Thu, 03/16/17 - 10:07 am

Valeant Pharmaceuticals

FDA Warns of Increased Risk of Serious Pancreatitis with Allergan’s Viberzi

RAPS.org

Thu, 03/16/17 - 10:02 am

Allergan antes up $90M in a CRISPR/Cas9 collaboration with Editas on eye diseases

Endpoints

Tue, 03/14/17 - 09:42 am

Allergan urges dry-eye sufferers to pump up their eye power

Fierce Pharma

Mon, 03/13/17 - 10:10 am

dry eye disease

Allergan scores an FDA OK for a new drug targeting night-time urination

Endpoints

Mon, 03/6/17 - 09:42 am

night urination

Serenity Pharmaceuticals

One more time: We're not buying Valeant, Allergan CEO insists

Fierce Pharma

Thu, 02/23/17 - 09:48 pm

Valeant Pharmaceuticals

Allergan to buy Zeltiq Aesthetics for about $2.48 bln

Yahoo/Reuters

Mon, 02/13/17 - 10:14 am

Allergan to boost investment in DTC for Kybella

Medical Marketing and Media

Thu, 02/9/17 - 11:15 am

DTC advertising

Biotech voices: Allergan CEO Saunders isn’t slowing down on a brisk pace of biotech dealmaking

Endpoints

Thu, 02/9/17 - 09:48 am

Allergan Tops Revenue Forecast

TheStreet.com

Wed, 02/8/17 - 09:25 pm

California Sues Teva, Allergan for Allegedly Blocking Generic Competition to Lidoderm

Motley Fool

Sun, 02/5/17 - 12:20 pm

Teva Pharmaceutical

Endo International

Earnings Preview: Merck set to solidify I/O lead, Sanofi still looking for deals and more

BioPharma Dive

Sat, 01/28/17 - 02:39 pm

Gilead Sciences

Allergan moves toward NDA after uterine fibroid drug's success

BioPharma Dive

Tue, 01/17/17 - 10:28 pm

uterine fibroids

ulipristal acetate

Pages